International Agency for Research on Cancer (IARC) - Summaries & Evaluations
trans-2-[(DIMETHYLAMINO)METHYLIMINO]-5-[2-(5-NITRO-2-
FURYL)VINYL]-1,3,4-OXADIAZOLE
VOL.: 7 (1974) (p. 147)
CAS No.: 25962-77-0
5. Summary of Data Reported and Evaluation
5.1 Animal carcinogenicity data
trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)vinyl]-1,3,4-oxadiazole is carcinogenic in rats following oral administration,
the only species and route tested. It produced mammary and intestinal
tract carcinomas.
5.2 Human carcinogenicity data
No case reports or epidemiological studies were available to the
Working Group.
Subsequent evaluation: Suppl. 7 (1987) (p. 62: Group 2B)
For definition of Groups, see Preamble Evaluation.
Last updated: 19 March 1998